High-flow nasal cannulae, bronchopulmonary dysplasia and retinopathy of prematurity
dc.availability.bitstream | ||
dc.contributor.author | Healy, L. I. | |
dc.contributor.author | Corcoran, Paul | |
dc.contributor.author | Murphy, Brendan P. | |
dc.date.accessioned | 2020-01-14T12:38:37Z | |
dc.date.available | 2020-01-14T12:38:37Z | |
dc.date.issued | 2019-09 | |
dc.date.updated | 2020-01-14T12:30:22Z | |
dc.description.abstract | Aims: To determine if HFNC use was associated with changes in incidence of BPD and ROP. Methods: This retrospective study examined premature infants (<30 weeks GA or <1500g) in a tertiary neonatal unit from 2010-2016. Patients were compared before and after introduction of HFNC. Further analysis of high-risk infants (<28 weeks GA or <750g or ventilated) compared those who received HFNC to those who did not across the whole period. Primary outcomes were incidence of BPD and ROP requiring surgery. Results: Incidence of BPD rose following the introduction of HFNC (82/232 (35.3%) after vs 33/251 (13.1%) before, p<0.001). On multivariate analysis, the chance of developing BPD after HFNC introduction remained higher (OR 4.353, 95% CI2.546-7.443). More infants received surgery for ROP following HFNC introduction (0/214 vs 11/205 (5.4%), p=<0.001). In the second analysis, the rate of BPD was higher in those who received HFNC (90/132 (68.1%) vs 33/153 (21.6%), p<0.001). Receiving HFNC demonstrated higher chance of BPD in multivariate analysis (OR 7.802, 95% CI 4.223-14.423). Rate of ROP surgery was higher in those who received HFNC (0/153 vs 13/134 (9.7%), p<0.001). Conclusions: In this study, use of HFNC was associated with significantly increased risk of adverse outcomes. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | P985 | en |
dc.identifier.citation | Healy, L. I., Corcoran, P. and Murphy, B. P. (2019) 'High-flow nasal cannulae, bronchopulmonary dysplasia and retinopathy of prematurity', Irish Medical Journal, 112(8), P985 (7pp). Available at: http://imj.ie/wp-content/uploads/2019/09/High-flow-Nasal-Cannulae-Bronchopulmonary-Dysplasia.pdf (Accessed: 14 January 2020). | en |
dc.identifier.endpage | 7 | en |
dc.identifier.issn | 0332-3102 | |
dc.identifier.issued | 8 | en |
dc.identifier.journaltitle | Irish Medical Journal | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/9502 | |
dc.identifier.volume | 112 | en |
dc.language.iso | en | en |
dc.publisher | Irish Medical Organisation | en |
dc.relation.uri | http://imj.ie/wp-content/uploads/2019/09/High-flow-Nasal-Cannulae-Bronchopulmonary-Dysplasia.pdf | |
dc.rights | © 2019, Irish Medical Journal. All rights reserved. | en |
dc.subject | High-flow nasal cannulae | en |
dc.subject | HFNC | en |
dc.subject | Premature | en |
dc.subject | Neonatal | en |
dc.subject | ROP surgery | en |
dc.title | High-flow nasal cannulae, bronchopulmonary dysplasia and retinopathy of prematurity | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- High-flow-Nasal-Cannulae-Bronchopulmonary-Dysplasia.pdf
- Size:
- 509.04 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: